You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-PRKACA (PRKACA) Antibodies

Full name:
anti-Protein Kinase A, alpha Antibodies (PRKACA)
On are 94 Protein Kinase A, alpha (PRKACA) Antibodies from 15 different suppliers available. Additionally we are shipping PRKACA Proteins (17) and PRKACA Kits (9) and many more products for this protein. A total of 125 PRKACA products are currently listed.
list all antibodies Gene Name GeneID UniProt
PRKACA 18747 P05132
PRKACA 5566 P17612
PRKACA 25636  

Show all species

Show all synonyms

Most Popular Reactivities for anti-PRKACA (PRKACA) Antibodies

Select your species and application

anti-Mouse (Murine) PRKACA Antibodies:

anti-Human PRKACA Antibodies:

anti-Rat (Rattus) PRKACA Antibodies:

All available anti-PRKACA Antibodies

Go to our pre-filtered search.

Top referenced anti-PRKACA Antibodies

  1. Human Polyclonal PRKACA Primary Antibody for EIA, IHC (p) - ABIN359056 : Tateyama, Rivolta, Clancy, Kass: Modulation of cardiac sodium channel gating by protein kinase A can be altered by disease-linked mutation. in The Journal of biological chemistry 2003 (PubMed)
    Show all 5 references for ABIN359056

  2. Human Monoclonal PRKACA Primary Antibody for WB - ABIN238374 : Beebe, Oyen, Sandberg, Frøysa, Hansson, Jahnsen: Molecular cloning of a tissue-specific protein kinase (C gamma) from human testis--representing a third isoform for the catalytic subunit of cAMP-dependent protein kinase. in Molecular endocrinology (Baltimore, Md.) 1990 (PubMed)
    Show all 5 references for ABIN238374

  3. Human Polyclonal PRKACA Primary Antibody for EIA, WB - ABIN453298 : Sugiyama, Chen, Hunter, Taffs, Sitkovsky: The dual role of the cAMP-dependent protein kinase C alpha subunit in T-cell receptor-triggered T-lymphocytes effector functions. in The Journal of biological chemistry 1993 (PubMed)

  4. Human Polyclonal PRKACA Primary Antibody for ICC, IF - ABIN408069 : Enns, Morton, Mangalindan, McKnight, Schwartz, Kaeberlein, Kennedy, Rabinovitch, Ladiges: Attenuation of age-related metabolic dysfunction in mice with a targeted disruption of the Cbeta subunit of protein kinase A. in The journals of gerontology. Series A, Biological sciences and medical sciences 2009 (PubMed)

  5. Human Polyclonal PRKACA Primary Antibody for ELISA, WB - ABIN562366 : Adachi, Kano, Saido, Murata: Visual screening and analysis for kinase-regulated membrane trafficking pathways that are involved in extensive beta-amyloid secretion. in Genes to cells : devoted to molecular & cellular mechanisms 2009 (PubMed)

More Antibodies against PRKACA Interaction Partners

Mouse (Murine) Protein Kinase A, alpha (PRKACA) interaction partners

  1. cAMP dependent protein kinase A (PKA) is a key intracellular factor mediating SHH (show SHH Antibodies) signaling through regulation of GLI3 (show GLI3 Antibodies) processing.

  2. this study shows illustrates for the first time the ability of protein kinase A to increase colony-stimulating factor 1 receptor (show CSF1R Antibodies) DNA methylation (show HELLS Antibodies) resulting in macrophage maturation

  3. these results suggest that the activation of 5-HT1D receptors selectively enhanced IA via the Gbetagamma of the Go-protein, PKA, and the sequential B-Raf (show SNRPE Antibodies)-dependent p38 MAPK (show MAPK14 Antibodies) signaling cascade.

  4. These data indicate that LPA increases CCN2 (show CTGF Antibodies) expression through the activation of PKC (show PKC Antibodies) and PKA. Thus, the regulatory functions of the PKC (show PKC Antibodies) and PKA pathways are implicated in the LPA-induced increase in CCN2 (show CTGF Antibodies) expression

  5. PKA phosphorylates the ATPase inhibitory factor 1 (show ATPIF1 Antibodies) and inactivates its capacity to bind and inhibit the mitochondrial H(+)-ATP synthase.

  6. Data suggest PRKAR1A (show PRKAR1A Antibodies) contains two structurally homologous cAMP-binding domains that exhibit marked differences in dynamic profiles in activation/inhibition of Prkaca; conservation of structure does not necessarily imply conservation of dynamics.

  7. Data (including data from studies in transgenic mice) suggest that constitutive activation of Prkaca in osteoblasts is sufficient to increase bone mass, favorably modify bone architecture, and improve mechanical properties of bone.

  8. Lin28a (show LIN28A Antibodies) protects against DCM through PKA/ROCK2 (show ROCK2 Antibodies) dependent pathway.

  9. We postulate that this novel interaction linking MVI with the PKA pathway could be important for targeting AKAP9 (show AKAP9 Antibodies)-PKA complex within cells and/or providing PKA to phosphorylate MVI tail domain.

  10. acidosis in inflamed tissues may be a decisive factor to regulate switching of PKA and PKCepsilon dependence via proton-sensing G-protein-coupled receptors.

Human Protein Kinase A, alpha (PRKACA) interaction partners

  1. PRKACA mutation is associated with Adrenocortical Adenomas.

  2. Differentiation of mesenchymal stem cells into beige (show LYST Antibodies)/brown adipocytes can be related via PKA modulation.

  3. FL-HCCs (show HCCS Antibodies) in children and young adults uniquely overexpress DNAJB1 (show DNAJB1 Antibodies)-PRKACA, which results in elevated cAMP-dependent PKA activity

  4. CFTR (show CFTR Antibodies) inhibition also affected cAMP/PKA-downstream events such as the increase in tyrosine phosphorylation, hyperactivated motility, and acrosome reaction.

  5. Results suggest that G protein alpha (show GNAO1 Antibodies) S subunit (Galphas (show GNAS Antibodies)) plays a tumor-promoting role in renal cell carcinoma (show MOK Antibodies) (RCC (show XRCC1 Antibodies)) and possibly acts through a protein kinase A (PKA)-dependent pathway.

  6. Phosphorylation of ezrin together with its binding to phosphatidylinositol-4,5-bisphosphate tethers the F508del CFTR to the actin cytoskeleton, stabilizing it on the apical membrane and rescuing the sub-membrane compartmentalization of cAMP and activated PKA.

  7. Data show that activated PKA phosphorylates the 19S subunit, Rpn6/PSMD11 (show PSMD11 Antibodies) (regulatory particle non-ATPase 6 (show MT-ATP6 Antibodies)/proteasome subunit D11) at Ser14.

  8. PKA phosphorylates the ATPase inhibitory factor 1 (show ATPIF1 Antibodies) and inactivates its capacity to bind and inhibit the mitochondrial H(+)-ATP synthase.

  9. DNAJB1 (show DNAJB1 Antibodies)-PRKACA was evaluated as a key driver of fibrolamellar carcinoma and as a candidate therapeutic target

  10. No somatic mutations were observed in PRKACA in a cohort of GH-secreting pituitary adenomas.

Pig (Porcine) Protein Kinase A, alpha (PRKACA) interaction partners

  1. ceramide as a potent physiological modulator of the Na(+)-ATPase (show DNAH8 Antibodies), participating in a regulatory network in kidney cells and counteracting the stimulatory effect of PKA via PKCzeta (show PRKCZ Antibodies)

  2. we demonstrate that PKA, PKC (show FYN Antibodies) and PI3K pathways crosstalk in porcine male germ cells to crucially regulate GSK3A (show GSK3a Antibodies) phosphorylation which subsequently controls cell motility.

Cow (Bovine) Protein Kinase A, alpha (PRKACA) interaction partners

  1. PKA and MEK (thus, also pERK) are the intracellular mediators downstream of GPR30 that induce the non-genomic suppression of GnRH-induced LH secretion from bovine AP cells by estradiol or G1

  2. Data indicate that mitochondrial cAMP-dependent protein kinase (PKA) activity is regulated by the protease calpain.

  3. structural basis of selectivity for protein kinase A in complex with Rho-kinase (show ROCK1 Antibodies) inhibitors by x-ray crystallography

  4. Purification and characterisation of protein kinase catalytic subunit (PKAcat) from bovine lens.

PRKACA Antigen Profile

Antigen Summary

Cyclic AMP-dependent protein kinase A (PKA) is an essential enzyme in the signaling pathway of the second messenger cAMP. Through phosphorylation of target proteins, PKA controls many biochemical events in the cell including regulation of metabolism, ion transport, and gene transcription. The PKA holoenzyme is composed of 2 regulatory and 2 catalytic subunits and dissociates from the regulatory subunits upon binding of cAMP.

Alternative names and synonyms associated with PRKACA

  • protein kinase, cAMP dependent, catalytic, alpha (Prkaca) antibody
  • protein kinase, cAMP-dependent, catalytic, alpha (PRKACA) antibody
  • protein kinase, cAMP-dependent, catalytic, alpha (Prkaca) antibody
  • protein kinase, cAMP-dependent, regulatory, type I, beta (PRKAR1B) antibody
  • Calpha antibody
  • Cs-PKA antibody
  • PKA antibody
  • PKACA antibody
  • PKCA1 antibody
  • PKCD antibody
  • PRKAR1 antibody

Protein level used designations for PRKACA

PKA C-alpha , cAMP-dependent protein kinase catalytic subunit alpha , sperm cAMP-dependent protein kinase catalytic subunit , protein kinase A catalytic subunit , protein kinase, cAMP-dependent, catalytic, alpha , C-alpha subunit , protein kinase A , cAMP-dependent protein kinase catalytic subunit C alpha , protein kinase A alpha , cAMP-dependent protein kinase type I-beta regulatory subunit

18747 Mus musculus
5566 Homo sapiens
397652 Sus scrofa
282322 Bos taurus
443094 Ovis aries
25636 Rattus norvegicus
403556 Canis lupus familiaris
5575 Homo sapiens
Selected quality suppliers for anti-PRKACA (PRKACA) Antibodies
Did you look for something else?